Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Prevalence of Secondary Arterial Hypertension (HIPRESH) with Prospective Systematic Screening

NCT06664255 is registered in ClinicalTrials.gov with University Hospital Padova as lead sponsor.

NCT NCT06664255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06664255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Prevalence of Secondary Arterial Hypertension (HIPRESH) with Prospective Systematic Screening
Lead sponsor
University Hospital Padova
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
January 31, 2023
Enrollment
1,400 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, hypertension resistant to conventional therapy, secondary hypertension, secondary hypertension renal arterial, secondary hypertension to endocrine disorders